for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

OncoTherapy Science, Inc.

4564.T

Latest Trade

90.00JPY

Change

1.00(+1.12%)

Volume

166,300

Today's Range

89.00

 - 

90.00

52 Week Range

89.00

 - 

175.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
89.00
Open
89.00
Volume
166,300
3M AVG Volume
13.18
Today's High
90.00
Today's Low
89.00
52 Week High
175.00
52 Week Low
89.00
Shares Out (MIL)
161.18
Market Cap (MIL)
14,506.42
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q2 2020 OncoTherapy Science Inc Earnings Release

Latest Developments

More

OncoTherapy Science unit signs research collaboration agreement to accelerate the Cancer Precision Medicine

OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research

OncoTherapy Science unit says business alliance with Thermo Fisher Scientific

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About OncoTherapy Science, Inc.

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.

Industry

Biotechnology & Drugs

Contact Info

6F, Kanagawa Science Park R&D Bldg. D

3-2-1, Sakado, Takatsu-ku

+81.44.8208251

https://www.oncotherapy.co.jp/

Executive Leadership

Kyoko Fujiya

President, President of Subsidiary, Representative Director

Suyoun Chung

Director of Clinical Development, Director

Takuya Tsunoda

Director

Hiroshi Yamaji

Director

Toyomasa Katagiri

Independent Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
44.92
Price To Book (MRQ)
2.97
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-53.69
Return on Equity (TTM)
-50.72

Latest News

Latest News

BRIEF-OncoTherapy Science unit says joint development with Japanese Foundation For Cancer Research

* Says co's unit Cancer Precision Medicine signs joint development agreement with Japanese Foundation For Cancer Research

BRIEF-OncoTherapy Science unit says business alliance with Thermo Fisher Scientific

* Says its unit, Cancer Precision Medicine forms business alliance with Thermo Fisher Scientific

BRIEF-OncoTherapy Science receives patent in Japan

* Says it received a patent (No.6159948 )for MELK specific inhibitors in Japan

BRIEF-OncoTherapy Science announces change of president

* Says co appoints Kazuo Yamamoto as new president, replacing Masaharu Mori who resigns

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up